I will be on holiday from 29th September to 9th October

The Most Effective Treatments for Chronic Insomnia (2026 Guide)

What actually works for chronic insomnia? CBT-I and ACT-I top the list — recommended first-line by NICE and the NHS — because they tackle root causes, not just symptoms like sleeping pills do.
By Tracy Hannigan, Sleep Therapist
Published: May 25, 2026
Updated: September 19, 2026
6 min read

In This Article You Will Learn

The most effective treatments for chronic insomnia are CBT-I (Cognitive Behavioural Therapy for Insomnia) and ACT-I (Acceptance and Commitment Therapy for Insomnia), both recommended as first-line approaches by NICE (2024) and the NHS.
Sleeping pills treat the symptom but not the cause. Their effects diminish over time and do not produce lasting change.
Sleep hygiene alone is insufficient for established chronic insomnia. The right treatment depends on whether behavioural patterns, cognitive patterns, or sleep anxiety is the primary maintaining factor.

Table of Contents

What Makes a Treatment Effective for Chronic Insomnia?

Chronic insomnia is defined as difficulty falling asleep, staying asleep, or waking too early, occurring at least three nights per week for at least three months, causing significant daytime distress or impairment 1. It is not primarily a disease — it is a learned pattern maintained by a combination of conditioned arousal, unhelpful beliefs about sleep, and sleep-effort behaviours.

This is why the most effective treatments address the maintaining mechanisms rather than the symptoms alone. A treatment that suppresses wakefulness tonight without addressing the underlying conditioning does not produce lasting change 2.

First-Line Treatments: The Evidence-Based Options

Cognitive Behavioural Therapy for Insomnia (CBT-I)

CBT-I is the most researched and most strongly recommended treatment for chronic insomnia. It is recommended as the first-line treatment by NICE 3, NHS England, the American Academy of Sleep Medicine 12, and the European Sleep Research Society 2.

CBT-I typically consists of four to eight sessions and includes the following components:

Stimulus control therapy restores the association between bed and sleep by restricting bed use to sleep only, removing wakefulness cues from the bedroom, and maintaining a consistent wake time. It is one of the most consistently effective single components across trials 5.

Sleep consolidation (sleep restriction therapy) temporarily limits time in bed to match actual sleep time, creating strong sleep pressure. This component produces the fastest improvements in sleep quality and efficiency, though it can feel demanding initially and works best with personalised guidance 5.

Cognitive restructuring identifies and challenges the beliefs that maintain hyperarousal: “I need 8 hours,” “I cannot function on less,” “My insomnia is permanent.” These beliefs generate the threat-monitoring that prevents sleep 6.

Relaxation techniques reduce the somatic arousal — physical tension, racing heart rate — that accompanies insomnia through progressive muscle relaxation, diaphragmatic breathing, and related approaches 5.

A systematic review and meta-analysis of 87 randomised controlled trials found CBT-I produces clinically significant improvements in how long it takes to fall asleep, wakefulness in the night and sleep efficiency, with effects maintained at 12 months 7.

Acceptance and Commitment Therapy for Insomnia (ACT-I)

ACT-I is an evidence-based alternative and complement to CBT-I, closely related to mindfulness-based approaches to insomnia, and particularly effective for people with significant sleep anxiety or those for whom CBT-I was too rigid or anxiety-provoking 8.

ACT-I targets the relationship with wakefulness rather than sleep behaviours directly. Its core insight is that the struggle against wakefulness generates more arousal than the wakefulness itself 9. It uses acceptance to reduce resistance to wakefulness, cognitive defusion to interrupt the arousal triggered by anxious sleep thoughts, values clarification to reconnect with meaningful daytime activity, and committed action to re-engage with life regardless of sleep quality.

A 2014 randomised controlled trial of mindfulness-based therapy for insomnia — which shares ACT-I’s core emphasis on changing one’s relationship with wakefulness rather than fighting it — found significant reductions in Insomnia Severity Index scores maintained at six months 8.

Integrated CBT-I and ACT-I

The most comprehensive approach combines both frameworks: CBT-I’s behavioural tools (stimulus control, sleep consolidation) with ACT-I’s psychological tools (acceptance, defusion, values). Tracy Hannigan uses this integrated approach in the Sleep Reboot and Sleep Reframe programmes, selecting and sequencing techniques based on what is maintaining each person’s insomnia. This integration is clinically indicated when both behavioural and psychological maintaining factors are present — the case for the majority of people with chronic insomnia.

Digital Programmes: Sleepio and Sleepstation

Digital CBT-I programmes provide an accessible option for mild-to-moderate insomnia.

Sleepio is a digital CBT-I programme developed by Professor Colin Espie at the University of Oxford and available free through some NHS trusts and employers. It is fully automated with no human therapist contact. One published randomised, placebo-controlled trial found sustained improvements in sleep efficiency and daytime functioning compared with both an active placebo condition and treatment-as-usual 10.

Sleepstation is a UK-based digital CBT-I programme with some team oversight, NHS-recommended, with published outcomes data.

Research consistently shows that human-guided CBT-I produces stronger outcomes than automated digital programmes, particularly for moderate-to-severe insomnia, high sleep anxiety, and people with prior CBT-I exposure 7.

Sleep Medications

Prescription Sleeping Pills

Z-drugs (zopiclone, zolpidem) and benzodiazepines reduce sleep onset latency and increase sleep duration in the short term. However, tolerance develops within two to four weeks, dependence is a significant risk, rebound insomnia occurs on stopping, and they do not address the conditioning that maintains chronic insomnia 3. NICE guidance limits prescriptions to short-term use and recommends CBT-I as the preferred treatment 3.

Daridorexant (Quviviq)

Daridorexant is a dual orexin receptor antagonist approved for use in the UK. It works by blocking wake-promoting signals rather than enhancing sedation, carries lower dependence risk, and has shown improvements in sleep in clinical trials 11. NHS access remains limited and patchy. Like other medications, it does not address the underlying conditioned arousal.

Melatonin

Prescription melatonin (Circadin) is licensed in the UK for short-term use in adults over 55 with primary insomnia. It is most effective for circadian rhythm disruption rather than the conditioned, anxiety-driven insomnia that characterises most chronic cases 4.

Why Sleep Hygiene Alone Is Insufficient

Sleep hygiene — consistent bedtimes, limiting caffeine, reducing screen use, exercising regularly — is a useful foundation for healthy sleep in people who do not yet have chronic insomnia. For established chronic insomnia (three or more months), sleep hygiene alone consistently fails to resolve the problem 7. The reason is that chronic insomnia is maintained by conditioned arousal and cognitive-emotional patterns that sleep hygiene does not address. By the time insomnia is chronic, the problem is in the conditioning, not the environment.


How to Choose the Right Treatment

ProfileRecommended Approach
Insomnia less than 3 months, no significant anxietySleep hygiene + stimulus control
Chronic insomnia, ready for behavioural changeCBT-I (therapist-guided or Sleepio/Sleepstation)
Chronic insomnia with high sleep anxietyACT-I or integrated CBT-I + ACT-I
Tried CBT-I, found it too rigid, anxiety remainsACT-I
Tapering off sleep medication1-on-1 therapy (Sleep Reframe)
Perimenopause-related insomniaIntegrated CBT-I + ACT-I; HRT for vasomotor symptoms only
Tried digital programme, insufficient improvement1-on-1 therapy with trained insomnia therapist


Tracy Hannigan is a qualified insomnia therapist at tracythesleepcoach.co.uk. She offers CBT-I and ACT-I online through the Sleep Reboot (6 weeks) and Sleep Reframe (12 weeks) programmes, for adults with chronic insomnia throughout the UK and internationally. Book a free 20-minute call to discuss which approach is right for you.

Frequently Asked Questions About The Best Insomnia Treatments

References

  1. American Academy of Sleep Medicine. International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR). Darien, IL: AASM; 2023. https://aasm.org/clinical-resources/international-classification-sleep-disorders/
  2. Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. https://doi.org/10.1111/jsr.12594
  3. National Institute for Health and Care Excellence. Insomnia. Clinical Knowledge Summary. NICE. https://cks.nice.org.uk/topics/insomnia/
  4. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307-349. doi:10.5664/jcsm.6470. https://doi.org/10.5664/jcsm.6470
  5. Bootzin RR, Epstein DR. Understanding and treating insomnia. Annu Rev Clin Psychol. 2011;7:435-458. https://doi.org/10.1146/annurev.clinpsy.3.022806.091516
  6. Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40(8):869-893. https://doi.org/10.1016/S0005-7967(01)00061-4
  7. Van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep Med Rev. 2018;38:3-16. https://doi.org/10.1016/j.smrv.2017.02.001
  8. Ong JC, Manber R, Segal Z, Xia Y, Shapiro S, Wyatt JK. A randomized controlled trial of mindfulness meditation for chronic insomnia. Sleep. 2014;37(9):1553-1563. https://doi.org/10.5665/sleep.4010
  9. Espie CA, Broomfield NM, MacMahon KMA, Macphee LM, Taylor LM. The attention-intention-effort pathway in the development of psychophysiologic insomnia: a theoretical review. Sleep Med Rev. 2006;10(4):215-245. https://doi.org/10.1016/j.smrv.2006.03.002
  10. Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35(6):769-781. https://doi.org/10.5665/sleep.1872
  11. Mignot E, Mayleben D, Fietze I, et al. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. Lancet Neurol. 2022;21(2):125-139. https://doi.org/10.1016/S1474-4422(21)00436-1
  12. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255-262. https://doi.org/10.5664/jcsm.8986

The information contained above is provided for information purposes only. The contents of this page are not intended to amount to advice and you should not rely on any of the contents of this page. Professional advice should be obtained before taking or refraining from taking any action as a result of the contents of this page. Tracy Hannigan disclaims all liability and responsibility arising from any reliance placed on any of the contents of this page.

Tracy, a red-haired sleep therapist, smiles warmly

I’m Tracy Hannigan, an insomnia therapist specialising in CBT‑I, ACTI and other evidence based approaches. Check out my services.